Pionyr Immunotherapeutics, Inc., a company developing first-in-class Myeloid TuningTM antibody therapeutics that enhance the body’s anti-tumor immunity by altering, or “tuning,”...
-- Landmark ZUMA-7 Study OS Data Reach Maturity Per Protocol, 5 Years After 1st Patient Randomized -- Kite, a Gilead Company (Nasdaq: NASDAQ:GILD), today announced the primary...
Benzinga - Gilead Sciences's (NASDAQ:GILD) short percent of float has risen 3.28% since its last report. The company recently reported that it has 15.76 million shares sold short,...
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 155.00 | 155.00 | 152.00 | +1.60 | +1.04% | 3.98M | London | |||
| 221.50 | 223.00 | 217.00 | +0.50 | +0.23% | 910.99K | London | |||
| 145.80 | 147.02 | 143.94 | +0.98 | +0.68% | 69.33M | London | |||
| 221.50 | 235.00 | 220.00 | -2.00 | -0.90% | 81.89K | London | |||
| 106.05 | 106.90 | 105.60 | -0.30 | -0.28% | 10.09M | London | |||
| 1,135.00 | 1,135.00 | 1,135.00 | +20.00 | +1.79% | 138.78K | London | |||
| 469.00 | 472.00 | 455.50 | +6.50 | +1.41% | 35.25K | London | |||
| 1,159.00 | 1,193.00 | 1,130.00 | +17.00 | +1.49% | 304.85K | London | |||
| 0.133 | 0.133 | 0.129 | -0.0025 | -1.85% | 251.56M | London | |||
| 11.50 | 12.15 | 11.50 | -0.60 | -4.96% | 719.59K | London | |||
| 89.30 | 89.79 | 89.07 | -0.24 | -0.27% | 87.75M | London | |||
| 0.12 | 0.13 | 0.13 | 0.00 | 0.00% | 0.00 | Aquis Exchange | |||
| 378.00 | 378.00 | 378.00 | +9.50 | +2.58% | 61.31K | London | |||
| 99.00 | 101.00 | 99.00 | -1.00 | -0.99% | 207.12K | London | |||
| 257.70 | 262.70 | 245.50 | -7.30 | -2.75% | 4.11M | London |